Therapeutic reflections in cholesterol homeostasis and gallstone disease: A review

Agostino Di Ciaula, David Q.H. Wang, Gabriella Garruti, Helen H. Wang, Ignazio Grattagliano, Ornella De Bari, Piero Portincasa

Research output: Contribution to journalReview article

12 Citations (Scopus)

Abstract

Cholesterol gallstone disease is one of the most prevalent and the most costly digestive diseases in Western countries. Its pathogenesis is a complex paradigm resulting from the interaction of genetic factors, hepatic hypersecretion of cholesterol, increased intestinal absorption of cholesterol, a constantly "supersaturated" bile, crystallization of biliary cholesterol, and gallbladder stasis. De novo cholesterol biosynthesis, biliary cholesterol output, and intestinal cholesterol absorption are therefore key steps involved in cholesterol homeostasis. Establishing the right pharmacological therapy for cholesterol gallstones is of major importance in Western healthcare systems. Certain drugs might independently influence cholesterol gallstone formation by blocking the 3-hydroxy-3-methylglutaryl- coenzyme A reductase and inhibiting cholesterol biosynthesis in the liver (statins) or blocking cholesterol absorption in the small intestine apical membrane by specifically inhibiting the Niemann-Pick C1-like 1 protein (ezetimibe). This review will focus on the possibility that statins and ezetimibe, by acting at different levels of cholesterol homeostasis, might represent novel therapeutic approaches to prevent cholesterol gallstones in selected subjects at risk.

Original languageEnglish (US)
Pages (from-to)1435-1447
Number of pages13
JournalCurrent Medicinal Chemistry
Volume21
Issue number12
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

Fingerprint

Gallstones
Homeostasis
Cholesterol
Therapeutics
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Intestinal Absorption
Biosynthesis
Liver
Crystallization
Gallbladder
Bile
Small Intestine
Oxidoreductases
Pharmacology

Keywords

  • Cholelithiasis
  • Cholesterol absorption
  • Cholesterol synthesis
  • Enterohepatic circulation
  • Metabolic syndrome
  • Niemann-Pick C1-like 1
  • Obesity

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology

Cite this

Di Ciaula, A., Wang, D. Q. H., Garruti, G., Wang, H. H., Grattagliano, I., De Bari, O., & Portincasa, P. (2014). Therapeutic reflections in cholesterol homeostasis and gallstone disease: A review. Current Medicinal Chemistry, 21(12), 1435-1447. https://doi.org/10.2174/09298673113206660271

Therapeutic reflections in cholesterol homeostasis and gallstone disease : A review. / Di Ciaula, Agostino; Wang, David Q.H.; Garruti, Gabriella; Wang, Helen H.; Grattagliano, Ignazio; De Bari, Ornella; Portincasa, Piero.

In: Current Medicinal Chemistry, Vol. 21, No. 12, 01.01.2014, p. 1435-1447.

Research output: Contribution to journalReview article

Di Ciaula, A, Wang, DQH, Garruti, G, Wang, HH, Grattagliano, I, De Bari, O & Portincasa, P 2014, 'Therapeutic reflections in cholesterol homeostasis and gallstone disease: A review', Current Medicinal Chemistry, vol. 21, no. 12, pp. 1435-1447. https://doi.org/10.2174/09298673113206660271
Di Ciaula, Agostino ; Wang, David Q.H. ; Garruti, Gabriella ; Wang, Helen H. ; Grattagliano, Ignazio ; De Bari, Ornella ; Portincasa, Piero. / Therapeutic reflections in cholesterol homeostasis and gallstone disease : A review. In: Current Medicinal Chemistry. 2014 ; Vol. 21, No. 12. pp. 1435-1447.
@article{d2af003aceb44c7bad5deb362d289d71,
title = "Therapeutic reflections in cholesterol homeostasis and gallstone disease: A review",
abstract = "Cholesterol gallstone disease is one of the most prevalent and the most costly digestive diseases in Western countries. Its pathogenesis is a complex paradigm resulting from the interaction of genetic factors, hepatic hypersecretion of cholesterol, increased intestinal absorption of cholesterol, a constantly {"}supersaturated{"} bile, crystallization of biliary cholesterol, and gallbladder stasis. De novo cholesterol biosynthesis, biliary cholesterol output, and intestinal cholesterol absorption are therefore key steps involved in cholesterol homeostasis. Establishing the right pharmacological therapy for cholesterol gallstones is of major importance in Western healthcare systems. Certain drugs might independently influence cholesterol gallstone formation by blocking the 3-hydroxy-3-methylglutaryl- coenzyme A reductase and inhibiting cholesterol biosynthesis in the liver (statins) or blocking cholesterol absorption in the small intestine apical membrane by specifically inhibiting the Niemann-Pick C1-like 1 protein (ezetimibe). This review will focus on the possibility that statins and ezetimibe, by acting at different levels of cholesterol homeostasis, might represent novel therapeutic approaches to prevent cholesterol gallstones in selected subjects at risk.",
keywords = "Cholelithiasis, Cholesterol absorption, Cholesterol synthesis, Enterohepatic circulation, Metabolic syndrome, Niemann-Pick C1-like 1, Obesity",
author = "{Di Ciaula}, Agostino and Wang, {David Q.H.} and Gabriella Garruti and Wang, {Helen H.} and Ignazio Grattagliano and {De Bari}, Ornella and Piero Portincasa",
year = "2014",
month = "1",
day = "1",
doi = "10.2174/09298673113206660271",
language = "English (US)",
volume = "21",
pages = "1435--1447",
journal = "Current Medicinal Chemistry",
issn = "0929-8673",
publisher = "Bentham Science Publishers B.V.",
number = "12",

}

TY - JOUR

T1 - Therapeutic reflections in cholesterol homeostasis and gallstone disease

T2 - A review

AU - Di Ciaula, Agostino

AU - Wang, David Q.H.

AU - Garruti, Gabriella

AU - Wang, Helen H.

AU - Grattagliano, Ignazio

AU - De Bari, Ornella

AU - Portincasa, Piero

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Cholesterol gallstone disease is one of the most prevalent and the most costly digestive diseases in Western countries. Its pathogenesis is a complex paradigm resulting from the interaction of genetic factors, hepatic hypersecretion of cholesterol, increased intestinal absorption of cholesterol, a constantly "supersaturated" bile, crystallization of biliary cholesterol, and gallbladder stasis. De novo cholesterol biosynthesis, biliary cholesterol output, and intestinal cholesterol absorption are therefore key steps involved in cholesterol homeostasis. Establishing the right pharmacological therapy for cholesterol gallstones is of major importance in Western healthcare systems. Certain drugs might independently influence cholesterol gallstone formation by blocking the 3-hydroxy-3-methylglutaryl- coenzyme A reductase and inhibiting cholesterol biosynthesis in the liver (statins) or blocking cholesterol absorption in the small intestine apical membrane by specifically inhibiting the Niemann-Pick C1-like 1 protein (ezetimibe). This review will focus on the possibility that statins and ezetimibe, by acting at different levels of cholesterol homeostasis, might represent novel therapeutic approaches to prevent cholesterol gallstones in selected subjects at risk.

AB - Cholesterol gallstone disease is one of the most prevalent and the most costly digestive diseases in Western countries. Its pathogenesis is a complex paradigm resulting from the interaction of genetic factors, hepatic hypersecretion of cholesterol, increased intestinal absorption of cholesterol, a constantly "supersaturated" bile, crystallization of biliary cholesterol, and gallbladder stasis. De novo cholesterol biosynthesis, biliary cholesterol output, and intestinal cholesterol absorption are therefore key steps involved in cholesterol homeostasis. Establishing the right pharmacological therapy for cholesterol gallstones is of major importance in Western healthcare systems. Certain drugs might independently influence cholesterol gallstone formation by blocking the 3-hydroxy-3-methylglutaryl- coenzyme A reductase and inhibiting cholesterol biosynthesis in the liver (statins) or blocking cholesterol absorption in the small intestine apical membrane by specifically inhibiting the Niemann-Pick C1-like 1 protein (ezetimibe). This review will focus on the possibility that statins and ezetimibe, by acting at different levels of cholesterol homeostasis, might represent novel therapeutic approaches to prevent cholesterol gallstones in selected subjects at risk.

KW - Cholelithiasis

KW - Cholesterol absorption

KW - Cholesterol synthesis

KW - Enterohepatic circulation

KW - Metabolic syndrome

KW - Niemann-Pick C1-like 1

KW - Obesity

UR - http://www.scopus.com/inward/record.url?scp=84899823115&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899823115&partnerID=8YFLogxK

U2 - 10.2174/09298673113206660271

DO - 10.2174/09298673113206660271

M3 - Review article

C2 - 24059227

AN - SCOPUS:84899823115

VL - 21

SP - 1435

EP - 1447

JO - Current Medicinal Chemistry

JF - Current Medicinal Chemistry

SN - 0929-8673

IS - 12

ER -